➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: January 25, 2021

DrugPatentWatch Database Preview

OXYCODONE AND ACETAMINOPHEN Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Oxycodone And Acetaminophen patents expire, and when can generic versions of Oxycodone And Acetaminophen launch?

Oxycodone And Acetaminophen is a drug marketed by Actavis Elizabeth, Barr, Duramed Pharms Barr, Halsey, Mallinckrodt, Mutual Pharm, Vintage Pharms, Vintage Pharms Llc, Watson Labs, Abhai Llc, Mikart Inc, Specgx Llc, Alvogen, Amneal Pharms, Amneal Pharms Ny, Anda Repository, Ascent Pharms Inc, Aurolife Pharma Llc, Cerovene Inc, Epic Pharma Llc, Granules Pharms, Lannett Co Inc, Mayne Pharma Inc, Mikart, Nesher Pharms, Nostrum Labs Inc, Novel Labs Inc, Rhodes Pharms, Sun Pharm Inds Inc, and Wes Pharma Inc. and is included in fifty NDAs.

The generic ingredient in OXYCODONE AND ACETAMINOPHEN is acetaminophen; oxycodone hydrochloride. There are sixty-six drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the acetaminophen; oxycodone hydrochloride profile page.

Summary for OXYCODONE AND ACETAMINOPHEN

US Patents:	0
Applicants:	30
NDAs:	50
Suppliers / Packagers:	29
Bulk Api Vendors:	1
Clinical Trials:	118
Patent Applications:	6
Formulation / Manufacturing:	see details
DailyMed Link:	OXYCODONE AND ACETAMINOPHEN at DailyMed

Drug patent expirations by year for OXYCODONE AND ACETAMINOPHEN

Recent Clinical Trials for OXYCODONE AND ACETAMINOPHEN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of Oklahoma	Early Phase 1
NYU Langone Health	Phase 4
University of Pennsylvania	Phase 4

See all OXYCODONE AND ACETAMINOPHEN clinical trials

Pharmacology for OXYCODONE AND ACETAMINOPHEN

Drug Class	Opioid Agonist
Mechanism of Action	Full Opioid Agonists

US Patents and Regulatory Information for OXYCODONE AND ACETAMINOPHEN

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Nesher Pharms	OXYCODONE AND ACETAMINOPHEN	acetaminophen; oxycodone hydrochloride	TABLET;ORAL	210079-001	Dec 28, 2017	AA	RX	No	No	Start Trial	Start Trial				Start Trial
Wes Pharma Inc	OXYCODONE AND ACETAMINOPHEN	acetaminophen; oxycodone hydrochloride	TABLET;ORAL	207510-001	Mar 21, 2018	AA	RX	No	No	Start Trial	Start Trial				Start Trial
Aurolife Pharma Llc	OXYCODONE AND ACETAMINOPHEN	acetaminophen; oxycodone hydrochloride	TABLET;ORAL	201972-003	Jul 15, 2013	AA	RX	No	No	Start Trial	Start Trial				Start Trial
Anda Repository	OXYCODONE AND ACETAMINOPHEN	acetaminophen; oxycodone hydrochloride	TABLET;ORAL	207834-001	Aug 15, 2019	AA	RX	No	No	Start Trial	Start Trial				Start Trial
Specgx Llc	OXYCODONE AND ACETAMINOPHEN	acetaminophen; oxycodone hydrochloride	TABLET;ORAL	040545-001	Jun 30, 2004	AA	RX	No	No	Start Trial	Start Trial				Start Trial
Granules Pharms	OXYCODONE AND ACETAMINOPHEN	acetaminophen; oxycodone hydrochloride	TABLET;ORAL	211708-001	Oct 31, 2019		DISCN	No	No	Start Trial	Start Trial				Start Trial
Mayne Pharma Inc	OXYCODONE AND ACETAMINOPHEN	acetaminophen; oxycodone hydrochloride	TABLET;ORAL	090177-004	Oct 20, 2008	AA	RX	No	No	Start Trial	Start Trial				Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter

McKesson

Johnson and Johnson

Mallinckrodt

Harvard Business School

Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.